Findings

What do systematic reviews say?

4 questions · 4 findings · 1 reviews · Drugs and Alcohol

No studies found 0 · 0%GRADE not reported 0 · 0%Very low 0 · 0%Low 2 · 50%Moderate 2 · 50%High 0 · 0%

Successful discontinuation of BZDs‐ post treatment Objective and subjective · patients with BZD harmful use, abuse or dependence

CBT (plus taper) probably leads to higher successful discontinuation of BZDs‐ post treatment Objective and… compared with taper (moderate certainty).

1 finding from 1 review

Psychosocial interventions for benzodiazepine harmful use, abuse or dependence 2015 · Cochrane Headline outcomes only
RR 1.4 [1.05, 1.86]
9 studies · 423 participants
Moderate

Successful discontinuation of BZDs‐ 12 month · patients with BZD harmful use, abuse or dependence

CBT (plus taper) showed no clear difference in successful discontinuation of BZDs‐ 12 month compared with taper (moderate certainty).

1 finding from 1 review

Psychosocial interventions for benzodiazepine harmful use, abuse or dependence 2015 · Cochrane Headline outcomes only
RR 1.42 [0.89, 2.28]
5 studies · 284 participants
Moderate

Reduce BZDs> 50% ‐ post treatment Objective · patients with BZD harmful use, abuse or dependence

CBT (plus taper) showed no clear difference in reduce BZDs> 50% ‐ post treatment Objective compared with taper (low certainty).

1 finding from 1 review

Psychosocial interventions for benzodiazepine harmful use, abuse or dependence 2015 · Cochrane Headline outcomes only
OR 0.93 [0.11, 8.18]
3 studies · 178 participants
Low

Reduce BZDs> 50% ‐ 12 month · patients with BZD harmful use, abuse or dependence

CBT (plus taper) showed no clear difference in reduce BZDs> 50% ‐ 12 month compared with taper (low certainty).

1 finding from 1 review

Psychosocial interventions for benzodiazepine harmful use, abuse or dependence 2015 · Cochrane Headline outcomes only
OR 1.07 [0.14, 8.21]
2 studies · 125 participants
Low